Malignant Brain Neoplasms

• CLINICAL_TRIALS research · 2026-02-05
  Clinical Trial Update: Zr-89 Crefmirlimab Berdoxam and Immuno-Positron Emission Tomography for the Imaging of Patients With Resectable Brain Tumors [Phase 1]

  A Phase 1 imaging trial evaluating a zirconium-89 labeled antibody (Zr-89 Crefmirlimab Berdoxam) for Immuno-PET imaging of resectable brain …

• CLINICAL_TRIALS research · 2025-12-22
  Clinical Trial Update: A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer [Phase 1]

  A Phase 1 study is evaluating the safety and tolerability of AZD1390 in combination with radiation therapy for brain cancer, including prima…

• CLINICAL_TRIALS research · 2025-08-05
  Clinical Trial Update: Application of the CD73-Targeted Probe ⁶⁸Ga-DOTA-mPNE PET/CT Imaging in the Diagnosis of Malignant Tumors [NA]

  Clinical trial update evaluating a CD73-targeted PET/CT imaging probe, 68Ga-DOTA-mPNE, for diagnosing malignant tumors. The study, sponsored…

• CLINICAL_TRIALS trial_result · 2025-06-27
  Clinical Trial Update: Topotecan by Intracerebral Clysis for Recurrent Primary Malignant Brain Tumors [Phase 1]

  Phase 1 clinical trial evaluating intracerebral infusion of topotecan for recurrent primary malignant brain neoplasms has completed, with re…

• CLINICAL_TRIALS withdrawal · 2016-05-17
  Clinical Trial Update: More Complete Removal of Malignant Brain Tumors by Fluorescence-Guided Surgery [Phase 2]

  A Phase 2 trial investigating fluorescence-guided surgery for removing malignant brain tumors has been withdrawn.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2015-04-02
  Clinical Trial Update: Bioequivalence Study of Temozolomide in Patients With Primary Tumors of the Central Nervous System [Phase 4]

  Phase 4 bioequivalence study of temozolomide in patients with primary malignant brain tumors has been completed and results posted.